Första AP-fonden’s Charles River Laboratories CRL Stock Holding History

Första AP-fonden’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,300	Closed	-$2.09M	–	561
2024 Q4	$2.09M	Buy	11,300 +700	+7%	+$135K	0.01%	540
2024 Q3	$2.09M	Buy	10,600 +1,100	+12%	+$229K	0.02%	533
2024 Q2	$1.96M	Sell	9,500 -800	-8%	-$181K	0.02%	523
2024 Q1	$2.79M	Buy	10,300 +1,500	+17%	+$358K	0.02%	506
2023 Q4	$2.08M	Buy	+8,800	New	+$1.73M	0.02%	531
2022 Q3	–	Sell	-11,200	Closed	-$2.4M	–	590
2022 Q2	$2.4M	Buy	+11,200	New	+$2.74M	0.03%	489
2022 Q1	–	Sell	-10,100	Closed	-$3.81M	–	574
2021 Q4	$3.81M	Sell	10,100 -11,300	-53%	-$4.39M	0.04%	444
2021 Q3	$8.83M	Buy	21,400 +6,300	+42%	+$2.62M	0.1%	238
2021 Q2	$5.59M	Buy	+15,100	New	+$5.04M	0.07%	356

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Första AP-fonden's CRL Position: Q1 2025 in Review

Första AP-fonden sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 11,300 shares — an estimated $2.09M sold.

Första AP-fonden first reported a position in CRL in Q2 2021 and held it in 9 quarters. The position peaked at $8.83M in Q3 2021. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

Första AP-fonden reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
Första AP-fonden sold 11,300 Charles River Laboratories shares in Q1 2025, an estimated $2.09M.
Första AP-fonden first reported a position in Charles River Laboratories in Q2 2021 and held it in 9 quarters.
Första AP-fonden's Charles River Laboratories position peaked at $8.83M in Q3 2021.
561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Första AP-fonden's 13F filing for Q1 2025, filed 12 May 2025.